Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Cited by (1,000)

Items 101–200 of 1,000

1. Diabetic dyslipidemia
   Marja‐Riitta Taskinen · 2002 · Atherosclerosis Supplements
2. Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol
   Xiao, Changting, Dash, Satya, Morgantini, Cecilia, Hegele, Robert A., Lewis, Gary F. · 2016 · Diabetes
3. Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
   Twickler, T.B., Dallinga-Thie, G.M., Cohn, J.S., Chapman, M.J. · 2004 · Circulation
4. New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
   James M. McKenney · 2004 · Archives of Internal Medicine
5. The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis
   Henry N. Ginsberg, Li-Shin Huang · 2000 · European Journal of Cardiovascular Prevention & Rehabilitation
6. Apolipoproteins: metabolic role and clinical biochemistry applications
   Dominiczak, Marek H, Caslake, Muriel J · 2011 · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
7. 7 Dyslipidaemia and obesity
   Jean‐Pierre Després · 1994 · Baillière s Clinical Endocrinology and Metabolism
8. Insulin Resistance and Atherosclerosis
   Babak Razani, Manu V. Chakravarthy, Clay F. Semenkovich · 2008 · Endocrinology and Metabolism Clinics of North America
9. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
   M. Castro Cabezas, Tjerk W.A. de Bruin, Harold W. de Valk, Carol C. Shoulders, Hans Jansen, D.W. Erkelens · 1993 · Journal of Clinical Investigation
10. Low-density lipoprotein particle number and risk for cardiovascular disease
    William C. Cromwell, James D. Otvos · 2004 · Current Atherosclerosis Reports
11. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism.
    Roche, Helen M, Gibney, Michael J · 2000 · The American Journal of Clinical Nutrition
12. Low‐density lipoprotein subclass patterns and lipoprotein response to a reduced‐fat diet in men
    Darlene M. Dreon, Harriett A. Fernstrom, Bonnie Miller, Ronald M. Krauss · 1994 · The FASEB Journal
13. An international multidisciplinary consensus statement on MAFLD and the risk of CVD
    Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, Virend Kristen Somers, Seung Up Kim, C. Anwar A. Chahal, Vincent Wai‐Sun Wong, Jingjing Cai, Michael David Shapiro, Mohammed Eslam et al. · 2023 · Hepatology International
14. Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL2Cholesterol
    Alberto Zambon, Samir S. Deeb, John E. Hokanson, B. Greg Brown, John D. Brunzell · 1998 · Arteriosclerosis Thrombosis and Vascular Biology
15. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study
    Miller, Michael, Seidler, Alexander, Moalemi, Azita, Pearson, Thomas A · 1998 · Journal of the American College of Cardiology
16. The importance of non–HDL cholesterol reporting in lipid management
    Michael Joseph Blaha, Roger Scott Blumenthal, Eliot A. Brinton, Terry A. Jacobson · 2008 · Journal of clinical lipidology
17. Lipoprotein Subfraction Changes in Normal Pregnancy: Threshold Effect of Plasma Triglyceride on Appearance of Small, Dense Low Density Lipoprotein1
    Naveed A. Sattar, Ian A. Greer, J Louden, Grace Lindsay, Michael McConnell, James Shepherd, Chris J. Packard · 1997 · The Journal of Clinical Endocrinology & Metabolism
18. A novel and simple method for quantification of small, dense LDL
    Tsutomu Hirano, Yasuki Ito, Haruhisa Saegusa, Gen Yoshino · 2003 · Journal of Lipid Research
19. Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
    Hiroaki Ikezaki, Elise Lim, L. Adrienne Cupples, Ching‐Ti Liu, Bela F. Asztalos, Ernst J. Schaefer · 2021 · Journal of the American Heart Association
20. Tree nuts and the lipid profile: a review of clinical studies
    Amy E. Griel, Penny M. Kris‐Etherton · 2006 · British Journal Of Nutrition
21. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
    Robert Boizel, Pierre‐Yves Benhamou, Bernard Lardy, François Laporte, Thérèse Foulon, S. Halimi · 2000 · Diabetes Care
22. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
    Y Hata, Hiroshi Mabuchi, Yasushi Saitō, Hiroshige Itakura, Genshi Egusa, Hideki Ito, Tamio Teramoto, Motoo Tsushima, Norio Tada, Shinichi Oikawa et al. · 2002 · Journal of Atherosclerosis and Thrombosis
23. Management of Primary Hyperlipidemia
    Richard J. Havel, Elliot Rapaport · 1995 · New England Journal of Medicine
24. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins
    Diane L. Tribble, Manfredi Rizzo, Alan Chait, Diane M Lewis, Patricia J. Blanche, Ronald M. Krauss · 2001 · The American Journal of Medicine
25. Lipoprotein atherogenicity: an overview of current mechanisms
    Bruce Arthur Griffin · 1999 · Proceedings of The Nutrition Society
26. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.
    Feingold Kr, Ronald M. Krauss, M Pang, William T. Doerrler, Per Bo Jensen, Carl Grünfeld · 1993 · The Journal of Clinical Endocrinology & Metabolism
27. Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol
    Yasuki Ito, Miki Fujimura, Motoko Ohta, Tsutomu Hirano · 2010 · Clinical Chemistry
28. Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins
    Pownall, Henry J, Brauchi, Danièle, Kilinç, Cumhur, Osmundsen, Karin, Pao, Quein, Payton-Ross, Charlotte, Gotto, Antonio M, Ballantyne, Christie M · 1999 · Atherosclerosis
29. Coronary Artery Disease Regression: Convincing Evidence for the Benefit of Aggressive Lipoprotein Management
    H. Superko, Ronald M. Krauss · 1994 · Circulation
30. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE family study
    Leon, Arthur S., Rice, Treva, Mandel, Stephen, Despres, Jean-Pierre, Bergeron, Jean, Gagnon, Jacques, Rao, D.C., Skinner, James S., Wilmore, Jack H., Bouchard, Claude · 2000 · Metabolism
31. Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)
    Wendy Jean Mack, Ronald M. Krauss, Howard Neil Hodis · 1996 · Arteriosclerosis Thrombosis and Vascular Biology
32. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity
    Jason M. R. Gill, Dalia Malkova · 2006 · Clinical Science
33. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk.
    Musunuru, Kiran, Orho-Melander, Marju, Caulfield, Michael P., Li, Shuguang, Salameh, Wael A., Reitz, Richard E., Berglund, Göran, Hedblad, Bo, Engström, Gunnar, Williams, Paul T. et al. · 2009 · Arteriosclerosis, Thrombosis, and Vascular Biology
34. The role of small, dense low density lipoprotein (LDL): a new look
    Chris J. Packard, MURIEL J. CASLAKE, James Shepherd · 2000 · International Journal of Cardiology
35. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)
    Benoı̂t Lamarche, Jean‐Pierre Després, Sital Moorjani, Bernard Cantin, Gilles R. Dagenais, Paul-J. Lupien · 1995 · The American Journal of Cardiology
36. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
    Hanak, Viktor, Munoz, Julian, Teague, Joe, Stanley, Alfred, Bittner, Vera · 2004 · The American Journal of Cardiology
37. Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study
    Nikolaos Tzenios, Erin Diane Lewis, David C. Crowley, Mohamad A. Chahine, Malkanthi Evans · 2021 · Metabolic Syndrome and Related Disorders
38. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice
    Hendrik N. van der Vliet, Frank G. Schaap, Johannes H.M. Levels, Roelof Ottenhoff, Norbert Looije, John G. Wesseling, Albert Kornelis Groen, Robert A.F.M. Chamuleau · 2002 · Biochemical and Biophysical Research Communications
39. Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial
    Nicholls, Stephen J., Lincoff, A. Michael, Bash, Dianna, Ballantyne, Christie M., Barter, Philip J., Davidson, Michael H., Kastelein, John J. P., Koenig, Wolfgang, McGuire, Darren K., Mozaffarian, Dariush et al. · 2018 · Clinical Cardiology
40. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
    Alexander Tenenbaum, Enrique Z. Fisman · 2012 · Cardiovascular Diabetology
41. Prospective Study of Small LDLs as a Risk Factor for Non–Insulin Dependent Diabetes Mellitus in Elderly Men and Women
    Melissa A. Austin, Leena Moilanen Mykkänen, Johanna Kuusisto, Karen L. Edwards, Carrie Nelson, Steven M. Haffner, Kalevi Pyörälà, Markku Laakso · 1995 · Circulation
42. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19.
    Patsy M. Nishina, John P. Johnson, Jürgen Κ. Naggert, Ronald M. Krauss · 1992 · Proceedings of the National Academy of Sciences
43. Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma
    Irene F. Gazi, Evangelia S. Lourida, Theodosios D. Filippatos, Vasilis Tsimihodimos, Moses Elisaf, Alexandros D. Tselepis · 2005 · Clinical Chemistry
44. Diabetes and Cardiovascular Disease
    Helaine E. Resnick, Barbara V. Howard · 2002 · Annual Review of Medicine
45. Mitochondrial injury in steatohepatitis
    Dominique Pessayre, Bernard Fromenty, Abdellah Mansouri · 2004 · European Journal of Gastroenterology & Hepatology
46. Novel Risk Factors for Atherosclerosis
    Iftikhar J. Kullo, Gerald T. Gau, Abdul Jamil Tajik · 2000 · Mayo Clinic Proceedings
47. Modification of Lipoproteins by Very Low-Carbohydrate Diets
    Volek, Jeff S., Sharman, Matthew J., Forsythe, Cassandra E. · 2005 · The Journal of Nutrition
48. Postprandial lipemia and cardiovascular disease
    Dianne A. Hyson, John C. Rutledge, Lars Berglund · 2003 · Current Atherosclerosis Reports
49. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
    Brunzell, John D, Ayyobi, Amir F · 2003 · The American Journal of Medicine
50. Impact of Obesity on Cardiovascular Disease
    Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric David Peterson, Peter Andrew McCullough · 2008 · Endocrinology and Metabolism Clinics of North America
51. Dense low density lipoproteins and coronary artery disease
    Ronald M. Krauss · 1995 · The American Journal of Cardiology
52. Serum triglycerides and risk of cardiovascular disease
    A.C.I. Boullart, Jacqueline d Graaf, Anton F. H. Stalenhoef · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
53. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
    H. Bryan Brewer · 1999 · The American Journal of Cardiology
54. Lipid disorders in type 1 diabetes
    Bruno L Vergès · 2009 · Diabetes & Metabolism
55. Unfavorable lipid profile in women with endometriosis
    Melo, Anderson Sanches, Rosa-e-Silva, Julio César, Rosa-e-Silva, Ana Carolina Japur de Sá, Poli-Neto, Omero Benedicto, Ferriani, Rui Alberto, Vieira, Carolina Sales · 2010 · Fertility and Sterility
56. Lipids and Stroke
    V C Hachinski · 1996 · Archives of Neurology
57. A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn)
    F. Mailly, Y. Tugrul, Paul W.A. Reymer, Taco Bruin, Mary Seed, Björn F. Groenemeyer, Anette Asplund-Carlson, David T. Vallance, ANTHONY F. WINDER, George J. Miller et al. · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
58. Untitled work
    Veenkamp · 2002 · 10.1161/hq0202.104059
59. Hypertriglyceridemia in the genomic era: a new paradigm
    Lewis, Gary F., Xiao, Changting, Hegele, Robert A. · 2015 · Endocrine Reviews
60. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
    Riadh Jemaa, Frédéric Fumeron, Odette Poirier, Laure Lecerf, A. Evans, Dominique Arveiler, G. Luc, Jean‐Pierre Cambou, Jean‐Marie Bard, Jean‐Charles Fruchart · 1996 · Journal of Lipid Research
61. Triglycerides as vascular risk factors: new epidemiologic insights.
    Kannel, William B, Vasan, Ramachandran S · 2009 · Current Opinion in Cardiology
62. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
    Guy De Backer, Giuseppe Ambrosio, Knut Borch‐Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, Shah B J Ebrahim, Ole Færgeman, Ian D. Graham, Giuseppe Mancia et al. · 2003 · PubMed
63. Hypertriglyceridemia and cardiovascular risk reduction
    Terry A. Jacobson, Michael J. Miller, Ernst J. Schaefer · 2007 · Clinical Therapeutics
64. Fatty liver, insulin resistance, and dyslipidemia
    Martin Adiels, Marja‐Riitta Taskinen, Jan Borén · 2008 · Current Diabetes Reports
65. Ezetimibe: cholesterol lowering and beyond
    Harold Edward Bays, David Neff, Joanne E. Tomassini, Andrew M. Tershakovec · 2008 · Expert Review of Cardiovascular Therapy
66. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype
    Khan, Syrah, Minihane, Anne-Marie, Talmud, Philippa J., Wright, John W., Murphy, Margaret C., Williams, Christine M., Griffin, Bruce A. · 2002 · Journal of Lipid Research
67. REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
    Henry N. Ginsberg · 2006 · The Journal of Clinical Endocrinology & Metabolism
68. Protein in optimal health: heart disease and type 2 diabetes
    Layman, Donald K, Clifton, Peter, Gannon, Mary C, Krauss, Ronald M, Nuttall, Frank Q · 2008 · The American Journal of Clinical Nutrition
69. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men
    Krauss, RM, Dreon, DM · 1995 · The American Journal of Clinical Nutrition
70. Association between Diabetes Mellitus, Hypothyroidism or Hyperadrenocorticism, and Atherosclerosis in Dogs
    Rebecka S. Hess, Philip H. Kass, Thomas J. Van Winkle · 2003 · Journal of Veterinary Internal Medicine
71. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
    Gero Miesenböck, B. Hölzl, Bernhard Föger, E Brandstätter, Bernhard Paulweber, Friedrich Sandhofer, Josef R. Patsch · 1993 · Journal of Clinical Investigation
72. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)
    Gerald Francis Watts, Sundhiya Mandalia, John N H Brunt, B M Slavin, D. JOHN COLTART, B. Lewis · 1993 · Metabolism
73. Atherogenic dyslipidemia and oxidative stress: a new look
    Manfredi Rizzo, Jelena Kotur‐Stevuljević, Kaspar K. Berneis, Giatgen A. Spinas, Giovam Battista Rini, Zorana Jelić‐Ivanović, Vesna Spasojević‐Kalimanovska, Jelena Vekić · 2009 · Translational research
74. Dyslipidemia in Type 1 Diabetes: A Masked Danger
    Bruno L Vergès · 2020 · Trends in Endocrinology and Metabolism
75. Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
    Christopher J. Deighan, MURIEL J. CASLAKE, Michael McConnell, J. Michael Boulton‐Jones, Christopher J. Packard · 2000 · American Journal of Kidney Diseases
76. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome
    Reena Kumari, Sandeep Kumar, Ravi Kant · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
77. Compensatory Hyperinsulinemia and the Development of an Atherogenic Lipoprotein Profile: The Price Paid to Maintain Glucose Homeostasis in Insulin-Resistant Individuals
    Gerald M. Reaven · 2005 · Endocrinology and Metabolism Clinics of North America
78. Measurement of Small Dense Low-density Lipoprotein Particles
    Tsutomu Hirano, Yasuki Ito, Gen Yoshino · 2005 · Journal of Atherosclerosis and Thrombosis
79. Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women
    Chang Tan, Lorne F. Forster, MURIEL J. CASLAKE, Dorothy K. Bedford, Tim D. G. Watson, M. McConnell, C.J. Packard, J. Shepherd · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
80. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.
    Heinz Drexel, Franz Wolfgang Amann, Jan Beran, Katharina Rentsch, RETO CANDINAS, Jörg Muntwyler, Antonia Luethy, Théo Gasser, Ferenc Folláth · 1994 · Circulation
81. Triglycerides and Risk for Coronary Heart Disease
    Patrick E. McBride · 2007 · JAMA
82. Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention
    Yuhao Zhou, Xiaofei Ye, Feifei Yu, Xiao Zhang, Yingyi Qin, Jian Lu, Jia He · 2013 · BMC Neurology
83. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men,,,
    Oksana A. Matvienko, Douglas S. Lewis, Mike Swanson, Beth Arndt, David L. Rainwater, Jeanne W. Stewart, D. Lee Alekel · 2002 · American Journal of Clinical Nutrition
84. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
    Mikko Syvänne, Maarit Ahola, Sanni Lahdenperä, Juhani Kahri, T Kuusi, Kari S. Virtanen, Marja‐Riitta Taskinen · 1995 · Journal of Lipid Research
85. Endothelial Dysfunction in Men With Small LDL Particles
    Juha Vakkilainen, Sari Mäkimattila, Anneli Seppälä‐Lindroos, Satu Vehkavaara, Sanni Lahdenperä, Per‐Henrik Groop, Marja‐Riitta Taskinen, Hannele Yki‐Järvinen · 2000 · Circulation
86. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus.
    Masoud El-Magadmi, Yasmeen A. Ahmad, Wajdi Turkie, Allen P. Yates, Naseem Sheikh, Robert M. Bernstein, Paul N. Durrington, Ian Laing, Ian N Bruce · 2006 · PubMed
87. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus
    Matthias Herz, Don Johns, Jesús Reviriego, Loren David Grossman, Chantal Godin, Santiago Durán, Federico Gustavo Hawkins, Heather Anne Lochnan, F. Escobar‐Jiménez, Philip A Hardin et al. · 2003 · Clinical Therapeutics
88. Differential effects of nicotinic acid in subjects with different LDL subclass patterns
    H. Robert Superko, Ronald M. Krauss · 1992 · Atherosclerosis
89. The effects of oral anti‐hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes
    John B. Buse, Meng Hee Tan, MELVIN J. PRINCE, Pamella Erickson · 2004 · Diabetes Obesity and Metabolism
90. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
    Austin, Melissa A, Rodriguez, Beatriz L, McKnight, Barbara, McNeely, Marguerite J, Edwards, Karen L, Curb, J.David, Sharp, Dan S · 2000 · The American Journal of Cardiology
91. Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method
    Tsutomu Hirano, Yasuki Ito, Shinji Koba, Miwako Toyoda, Ayako Ikejiri, Haruhisa Saegusa, Junichi Yamazaki, Gen Yoshino · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
92. Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-Induced Myocardial Ischemia in Middle-Aged Men and Women
    Henry N. Ginsberg, Jeff Jones, William S. Blaner, Alicia Thomas, Wahida Karmally, Leslie Fields, David K. Blood, Melissa Dowd Begg · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
93. Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein
    Fredrik Karpe, Per Tornvall, Thomas Olivecrona, George A. Steiner, Lars A. arlson, Anders Hamsten · 1993 · Atherosclerosis
94. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
    Packard, Chris J · 2006 · Current Opinion in Lipidology
95. Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial
    Sally Chiu, Paul T. Williams, Ronald M. Krauss · 2017 · PLoS ONE
96. Prevention Conference V
    Scott M. Grundy, Terry L. Bazzarre, James I. Cleeman, Ralph B. D’Agostino, Martha N. Hill, Nancy Houston Miller, William Bernard Kannel, Ronald M. Krauss, Harlan M. Krumholz, Ronald M. Lauer et al. · 2000 · Circulation
97. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
    Per Fogelstrand, Jan Borén · 2011 · Nutrition Metabolism and Cardiovascular Diseases
98. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4
    Carol M. Forsblom, T Sane, Per‐Henrik Groop, K. J. Tötterman, Milla Kallio, Carola Saloranta, Leena Laasonen, Paula A. Summanen, Mauri Lepäntalo, Leila Laatikainen et al. · 1998 · Diabetologia
99. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small, dense LDL.
    Stalenhoef, Anton FH, de Graaf, Jacqueline · 2008 · Current Opinion in Lipidology
100. New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
     Bruno L Vergès · 2005 · Diabetes & Metabolism